Gregory Fortunoff, Director at Medite Cancer Diagnostics, Inc. (MDIT), bought 2,666,668 shares at $0.75 ($2.0M) on 2018-04-04, disclosed to the SEC on 2018-05-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.75 | 1,333,334 | $1.0M | 50.0% |
| 2 | $0.75 | 1,333,334 | $1.0M | 50.0% |
| Total | $0.75 avg | 2,666,668 | $2.0M | 100% |
| Filing → |
| AMAC | BUY | 2007-12-05 | $97K | — | Filing → |
| AMAC | BUY | 2007-11-30 | $43K | — | Filing → |
| AMAC | BUY | 2007-11-27 | $15K | — | Filing → |